The preliminary clinical experience with laparoscopic duodenojejunal bypass for treatment of type 2 diabetes mellitus in non-morbidly obese patients: The 1-year result in a single institute

Surgical Endoscopy

Volumn 26, Issue 11, 2012, Pages 3287-3292

  Paik, Kwang Yeol ^a   Kim, Wook ^a   Song, Ki Ho ^a   Kwon, Hyuk Sang ^a   Kim, Mee Kyoung ^a   Kim, Eungkook ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Laparoscopic duodenojejunal bypass; Type 2 diabetes mellitus

Indexed keywords

GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN GLARGINE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; SITAGLIPTIN; VOGLIBOSE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LAPAROSCOPIC DUODENOJEJUNAL BYPASS; LAPAROSCOPIC SURGERY; LENGTH OF STAY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPERATION DURATION; PATIENT SAFETY; POSTOPERATIVE ILEUS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84871620348     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-012-2341-1     Document Type: Article

References (18)

1. Rubino F, Marescaux J (2004) Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1-11 (Pubitemid 38176365)
2. Rubino F (2006) Bariatric surgery: effects on glucose homeostasis. Curr Opin Clin Nutr Metab Care 9:497-507 (Pubitemid 44097824)
3. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L (1995) Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-350 discussion 350-332
4. Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Intern Med 123:261-266
5. Creutzfeldt W (1979) The incretin concept today. Diabetologia 16:75-85 (Pubitemid 9231263)
6. Korner J, Bessler M, Cirilo LJ, Conwell IM, Daud A, Restuccia NL, Wardlaw SL (2005) Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 90: 359-365 (Pubitemid 40116682)
7. le Roux CW, Aylwin SJB, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108-114 (Pubitemid 43054062)
8. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741-749 (Pubitemid 44629948)
9. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A, Nanni G, Castagneto M, Calvani M, Mingrone G (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025-2031 (Pubitemid 44509976)
10. Morinigo R, Lacy AM, Casamitjana R, Delgado S, Gomis R, Vidal J (2006) GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 16: 1594-1601 (Pubitemid 46032812)
11. Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007) Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 3:195-197 (Pubitemid 46444706)
12. Lee HC, Kim MK, Kwon HS, Kim E, Song KH (2010) Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg 20:1530-1535
13. Ramos AC, Galvao Neto MP, de Souza YM, Galvao M, Murakami AH, Silva AC, Canseco EG, Santamaria R, Zambrano TA (2009) Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI\30 kg/m2 (LBMI). Obes Surg 19:307-312
14. Ferzli GS, Dominique E, Ciaglia M, Bluth MH, Gonzalez A, Fingerhut A (2009) Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 33:972-979
15. Geloneze B, Geloneze SR, Fiori C, Stabe C, Tambascia MA, Chaim EA, Astiarraga BD, Pareja JC (2009) Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 19:1077-1083
16. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S, Phillips GL II, Robertson RP, Rubino F, Kahn R, Kirkman MS (2009) How do we define cure of diabetes? Diabetes Care 32:2133-2135
17. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D (2003) Effect of laparoscopic Rouxen Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467-484 discussion 484-465
18. Torquati A, Lutfi R, Abumrad N, Richards WO (2005) Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 9:1112-1116 discussion 1117-1118